Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer von BEREK, Jonathan, TAYLOR, Peyton, MCGUIRE, William, SMITH, L. Mary, SCHULTES, Birgit, NICODEMUS, Christopher F

Volltext

Randomized, Placebo-Controlled Study of Oregovomab for Consolidation of Clinical Remission in Patients With Advanced Ovarian Cancer von BEREK, Jonathan S, TAYLOR, Peyton T, GORDON, Alan, CUNNINGHAM, Mary J, FINKLER, Neil, ORR, James JR, RIVKIN, Saul, SCHULTES, Birgit C, WHITESIDE, Theresa L, NICODEMUS, Christopher F

Volltext

Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy von Nicodemus, Christopher F., MD, Wang, Lin, MD, Lucas, Julie, PhD, Varghese, Bindu, PhD, Berek, Jonathan S., MD, MMS

Volltext

Antibody-based immunotherapy of solid cancers: progress and possibilities von Nicodemus, Christopher F

Volltext

CA125 Velocity at Relapse is a Highly Significant Predictor of Survival Post Relapse : Results of a 5-year Follow-up Survey to a Randomized Placebo-controlled Study of Maintenance... von BEREK, Jonathan S, TAYLOR, Peyton T, NICODEMUS, Christopher F

Volltext

Biologic and Immunologic Therapies for Ovarian Cancer von Berek, Jonathan S, Schultes, Birgit C, Nicodemus, Christopher F

Volltext

IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer von Markov, Spas Dimitrov, Caffrey, Thomas C., O'Connell, Kelly A., Grunkemeyer, James A., Shin, Simon, Hanson, Ryan, Patil, Prathamesh P., Shukla, Surendra K., Gonzalez, Daisy, Crawford, Ayrianne J., Vance, Krysten E., Huang, Ying, Eberle, Kirsten C., Radhakrishnan, Prakash, Grandgenett, Paul M., Singh, Pankaj K., Madiyalakan, Ragupathy, Daniels-Wells, Tracy R., Penichet, Manuel L., Nicodemus, Christopher F., Poole, Jill A., Jaffee, Elizabeth M., Hollingsworth, Michael A., Mehla, Kamiya

Volltext

Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors von Mehla, Kamiya, Tremayne, Jarrod, Grunkemeyer, James A., O’Connell, Kelly A., Steele, Maria M., Caffrey, Thomas C., Zhu, Xinyi, Yu, Fang, Singh, Pankaj K., Schultes, Birgit C., Madiyalakan, Ragupathy, Nicodemus, Christopher F., Hollingsworth, Michael A.

Volltext

Discordant Biological and Toxicological Species Responses to TLR3 Activation von Mitchell, William M, Nicodemus, Christopher F, Carter, William A, Horvath, Joseph C, Strayer, David R

Volltext

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy von Daniels-Wells, Tracy R, Helguera, Gustavo, Leuchter, Richard K, Quintero, Rafaela, Kozman, Maggie, Rodríguez, José A, Ortiz-Sánchez, Elizabeth, Martínez-Maza, Otoniel, Schultes, Birgit C, Nicodemus, Christopher F, Penichet, Manuel L

Volltext

Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells von Daniels, Tracy R., Leuchter, Richard K., Quintero, Rafaela, Helguera, Gustavo, Rodríguez, José A., Martínez-Maza, Otoniel, Schultes, Birgit C., Nicodemus, Christopher F., Penichet, Manuel L.

Volltext

The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel : A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced O... von BRALY, Patricia, NICODEMUS, Christopher F, METHOD, Michael, CHU, Christina, COLLINS, Yvonne, EDWARDS, Robert, GORDON, Alan, MCGUIRE, William, SCHOONMAKER, Christopher, WHITESIDE, Theresa, SMITH, Mary

Volltext

CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients von Gordon, Alan N, Schultes, Birgit C, Gallion, Holly, Edwards, Robert, Whiteside, Theresa L, Cermak, Jennifer M, Nicodemus, Christopher F

Volltext

Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer von Möbus, Volker J., Baum, Richard P., Bolle, Marcus, Kreienberg, Rolf, Noujaim, Antoine A., Schultes, Birgit C., Nicodemus, Christopher F.

Volltext

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer von Schultes, Birgit C, Smith, L Mary, Nicodemus, Christopher F

Volltext

Final survival follow-up and translational associations using interval indirect immunization with oregovomab (O) and poly ICLC in patients (pts) with recurrent platinum-resistant o... von Holloway, Robert W., Temkin, Sarah Madhu, Gordon, Sarah W., Gupta, Sunil, Nicodemus, Christopher F., Madiyalakan, Madi, McGuire, William P.

Volltext

Role of monoclonal antibodies in tumor-specific immunity von Nicodemus, Christopher F, Smith, L Mary, Schultes, Birgit C

Volltext

Monoclonal antibody therapy of ovarian cancer von Nicodemus, Christopher F, Berek, Jonathan S

Volltext

Using antibodies in tumour immunotherapy von Schultes, Birgit C, Nicodemus, Christopher F

Volltext

IgE-based therapeutic combination enhances anti-tumor response in preclinical models of pancreatic cancer von Markov, Spas Dimitrov, Caffrey, Thomas C., O’Connell, Kelly A., Grunkemeyer, James A., Shin, Simon, Hanson, Ryan, Patil, Prathamesh P., Shukla, Surendra K., Gonzalez, Daisy, Crawford, Ayrianne J., Vance, Krysten E., Huang, Ying, Eberle, Kirsten C., Radhakrishnan, Prakash, Grandgenett, Paul M., Singh, Pankaj K., Madiyalakan, Ragupathy, Daniels-Wells, Tracy R., Penichet, Manuel L., Nicodemus, Christopher F., Poole, Jill A., Jaffee, Elizabeth M., Hollingsworth, Michael A., Mehla, Kamiya

Volltext